Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves Perrigo ANDA for generic Duac gel
Duac Gel is indicated for the topical treatment of inflammatory acne vulgaris. Perrigo chairman, president and CEO Joseph Papa said, "We’re pleased to bring this new topical product
Duac Gel is indicated for the topical treatment of inflammatory acne vulgaris. Perrigo chairman, president and CEO Joseph Papa said, "We’re pleased to bring this new topical product
Production using the new expanded capacity at its multi-product cGMP active pharmaceutical ingredient (API) manufacturing facility commenced on 1 June 2012. The investment matches the solids handling equipment
With the new agreement, BioDiem gains exclusive license to the technology which, although in development for hepatitis, may also have applicability in a range of other diseases. As
The FDA approved Belviq as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index
As part of the merger, Cornerstone will assume the responsibility to market and promote Cardene I.V. (nicardipine hydrochloride) and Retavase (Reteplase). As part of the agreement Cornerstone has
The vaccine technology mainly focuses on Dengue fever along with other infectious diseases that include Murray River encephalitis and Japanese encephalitis. Under the agreement BioDiem is provided with
Under the collaboration, Tocagen will use MRI Interventions’ ClearPoint neuro intervention system at selected sites in its ongoing investigational clinical trial for the delivery of Toca 511 into
Under the agreement, Patheon will formulate, fill and finish ANX-188 drug product for use in clinical trials, including the Phase 3 study of ANX-188 that ADVENTRX plans to
The FVIII will primarily be used in the treatment of hemophilia A. The only approval now remaining for Taibang’s commercial production of FVIII is the SFDA’s good manufacturing
Neviah Genomics, which is the first company to be funded within the framework of Merck Serono’s Israel Bioincubator program, is expected to focus on the discovery and development